M. Troy

Acceleron Pharma (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

3h-index85citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(4), Genetic Neurodegenerative Diseases(1), Ubiquitin and proteasome pathways(1), Adipose Tissue and Metabolism(1), Exercise and Physiological Responses(1)

Publications5 total

Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease
Scientific Reports·2019· 49 citedOpen Access
Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
Journal of Pharmacology and Experimental Therapeutics·2018· 26 citedOpen Access
ACE-083, a locally-acting TGF-β; superfamily ligand trap, increases muscle mass and strength in a mouse model of Duchenne muscular dystrophy
Neuromuscular Disorders·2016· 3 cited
ACE-083 increases muscle hypertrophy and strength in C57BL/6 mice
Neuromuscular Disorders·2015· 6 cited
ACE-2494, a novel GDF ligand trap, increases muscle and bone mass upon systemic administration in mice
Neuromuscular Disorders·2015· 1 cited

Frequent Co-authors

R. Scott Pearsall(5), Monique V. Davies(5), M. Cannell(5), Dianne Sako(5), Roselyne Castonguay(5), Katia Liharska(4), Asya V. Grinberg(4), Jeffrey J. Widrick(3), Aaron W. Mulivor(2), Samantha Wallner(2), Sarah Keates(2), Ravi Kumar(2), Jamie Strand(2), Lavanya Krishnan(2), K. Heveron(2), Marat Alimzhanov(2), R. Kumar(2), J. Li(1), Matthew Spaits(1), Rajasekhar N.V.S. Suragani(1)